{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,10,21]],"date-time":"2026-10-21T00:24:26Z","timestamp":1792542266971,"version":"4.5.0"},"reference-count":28,"publisher":"Elsevier BV","issue":"5","license":[{"start":{"date-parts":[[2024,11,1]],"date-time":"2024-11-01T00:00:00Z","timestamp":1730419200000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/tdm\/userlicense\/1.0\/"},{"start":{"date-parts":[[2024,11,1]],"date-time":"2024-11-01T00:00:00Z","timestamp":1730419200000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/legal\/tdmrep-license"},{"start":{"date-parts":[[2024,7,4]],"date-time":"2024-07-04T00:00:00Z","timestamp":1720051200000},"content-version":"vor","delay-in-days":0,"URL":"http:\/\/creativecommons.org\/licenses\/by\/4.0\/"}],"funder":[{"DOI":"10.13039\/501100000659","name":"NIHR Trainees Coordinating Centre","doi-asserted-by":"publisher","id":[{"id":"10.13039\/501100000659","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/501100000272","name":"National Institute for Health and Care Research","doi-asserted-by":"publisher","id":[{"id":"10.13039\/501100000272","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/100014653","name":"NIHR Manchester Biomedical Research Centre","doi-asserted-by":"publisher","award":["NIHR203308"],"award-info":[{"award-number":["NIHR203308"]}],"id":[{"id":"10.13039\/100014653","id-type":"DOI","asserted-by":"publisher"}]}],"content-domain":{"domain":["clinicalkey.fr","clinicalkey.jp","clinicalkey.com.au","clinicalkey.es","clinicalkey.com","journal.chestnet.org","elsevier.com","sciencedirect.com"],"crossmark-restriction":true},"short-container-title":["CHEST"],"published-print":{"date-parts":[[2024,11]]},"DOI":"10.1016\/j.chest.2024.06.3790","type":"journal-article","created":{"date-parts":[[2024,7,9]],"date-time":"2024-07-09T19:00:52Z","timestamp":1720551652000},"page":"987-997","update-policy":"https:\/\/doi.org\/10.1016\/elsevier_cm_policy","source":"Crossref","is-referenced-by-count":22,"title":["Rethinking Blood Eosinophils for Assessing Inhaled Corticosteroids Response in COPD"],"prefix":"10.1016","volume":"166","author":[{"ORCID":"https:\/\/orcid.org\/0000-0002-4675-9616","authenticated-orcid":false,"given":"Alexander G.","family":"Mathioudakis","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0002-2218-503X","authenticated-orcid":false,"given":"Sebastian","family":"Bate","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0002-8620-3655","authenticated-orcid":false,"given":"Pradeesh","family":"Sivapalan","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0003-4036-0521","authenticated-orcid":false,"given":"Jens-Ulrik St\u00e6hr","family":"Jensen","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0001-8918-7075","authenticated-orcid":false,"given":"Dave","family":"Singh","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0001-6355-6362","authenticated-orcid":false,"given":"J\u00f8rgen","family":"Vestbo","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"78","reference":[{"issue":"2","key":"10.1016\/j.chest.2024.06.3790_bib1","doi-asserted-by":"crossref","first-page":"410","DOI":"10.1183\/13993003.01359-2015","article-title":"Treatable traits: toward precision medicine of chronic airway diseases","volume":"47","author":"Agusti","year":"2016","journal-title":"Eur Respir J"},{"issue":"5","key":"10.1016\/j.chest.2024.06.3790_bib2","doi-asserted-by":"crossref","DOI":"10.1183\/13993003.00164-2019","article-title":"Global Strategy for the Diagnosis, Management, and Prevention of Chronic Obstructive Lung Disease: the GOLD science committee report 2019","volume":"53","author":"Singh","year":"2019","journal-title":"Eur Respir J"},{"issue":"9240","key":"10.1016\/j.chest.2024.06.3790_bib3","doi-asserted-by":"crossref","first-page":"1480","DOI":"10.1016\/S0140-6736(00)02872-5","article-title":"Sputum eosinophilia and short-term response to prednisolone in chronic obstructive pulmonary disease: a randomised controlled trial","volume":"356","author":"Brightling","year":"2000","journal-title":"Lancet"},{"issue":"18","key":"10.1016\/j.chest.2024.06.3790_bib4","doi-asserted-by":"crossref","first-page":"1671","DOI":"10.1056\/NEJMoa1713901","article-title":"Once-daily single-inhaler triple versus dual therapy in patients with COPD","volume":"378","author":"Lipson","year":"2018","journal-title":"N\u00a0Engl J Med"},{"issue":"1","key":"10.1016\/j.chest.2024.06.3790_bib5","doi-asserted-by":"crossref","first-page":"35","DOI":"10.1056\/NEJMoa1916046","article-title":"Triple inhaled therapy at two glucocorticoid doses in moderate-to-very-severe COPD","volume":"383","author":"Rabe","year":"2020","journal-title":"N\u00a0Engl J Med"},{"issue":"10125","key":"10.1016\/j.chest.2024.06.3790_bib6","doi-asserted-by":"crossref","first-page":"1076","DOI":"10.1016\/S0140-6736(18)30206-X","article-title":"Extrafine inhaled triple therapy versus dual bronchodilator therapy in chronic obstructive pulmonary disease (TRIBUTE): a double-blind, parallel\u00a0group, randomised controlled trial","volume":"391","author":"Papi","year":"2018","journal-title":"Lancet"},{"issue":"2","key":"10.1016\/j.chest.2024.06.3790_bib7","doi-asserted-by":"crossref","first-page":"117","DOI":"10.1016\/S2213-2600(18)30006-7","article-title":"Predictors of exacerbation risk and response to budesonide in patients with chronic obstructive pulmonary disease: a post-hoc analysis of three randomised trials","volume":"6","author":"Bafadhel","year":"2018","journal-title":"Lancet Respir Med"},{"issue":"4","key":"10.1016\/j.chest.2024.06.3790_bib8","doi-asserted-by":"crossref","first-page":"523","DOI":"10.1164\/rccm.201502-0235LE","article-title":"Blood eosinophils: a biomarker of response to extrafine beclomethasone\/formoterol in chronic obstructive pulmonary disease","volume":"192","author":"Siddiqui","year":"2015","journal-title":"Am J Respir Crit Care Med"},{"issue":"7","key":"10.1016\/j.chest.2024.06.3790_bib9","first-page":"CD002991","article-title":"Inhaled corticosteroids for stable chronic obstructive pulmonary disease","volume":"2012","author":"Yang","year":"2012","journal-title":"Cochrane Database Syst Rev"},{"issue":"3","key":"10.1016\/j.chest.2024.06.3790_bib10","article-title":"Inhaled steroids and risk of pneumonia for chronic obstructive pulmonary disease","volume":"2014","author":"Kew","year":"2014","journal-title":"Cochrane Database Syst Rev"},{"issue":"5","key":"10.1016\/j.chest.2024.06.3790_bib11","doi-asserted-by":"crossref","first-page":"906","DOI":"10.1183\/09031936.00146306","article-title":"Eosinophilic airway inflammation and exacerbations of COPD: a randomised controlled trial","volume":"29","author":"Siva","year":"2007","journal-title":"Eur Respir J"},{"issue":"3","key":"10.1016\/j.chest.2024.06.3790_bib12","doi-asserted-by":"crossref","first-page":"669","DOI":"10.1164\/ajrccm\/145.3.669","article-title":"Effect of an inhaled corticosteroid on airway inflammation and symptoms in asthma","volume":"145","author":"Djukanovic","year":"1992","journal-title":"Am Rev Respir Dis"},{"issue":"1","key":"10.1016\/j.chest.2024.06.3790_bib13","doi-asserted-by":"crossref","first-page":"22","DOI":"10.1164\/ajrccm.159.1.9706006","article-title":"Effect of inhaled budesonide on lung function and airway inflammation. Assessment by various inflammatory markers in mild asthma","volume":"159","author":"Lim","year":"1999","journal-title":"Am J Respir Crit Care Med"},{"issue":"5","key":"10.1016\/j.chest.2024.06.3790_bib14","doi-asserted-by":"crossref","first-page":"1902119","DOI":"10.1183\/13993003.02119-2019","article-title":"Change in blood eosinophils following treatment with inhaled corticosteroids may predict long-term clinical response in COPD","volume":"55","author":"Mathioudakis","year":"2020","journal-title":"Eur Respir J"},{"issue":"7245","key":"10.1016\/j.chest.2024.06.3790_bib15","doi-asserted-by":"crossref","first-page":"1297","DOI":"10.1136\/bmj.320.7245.1297","article-title":"Randomised, double blind, placebo controlled study of fluticasone propionate in patients with moderate to severe chronic obstructive pulmonary disease: the ISOLDE trial","volume":"320","author":"Burge","year":"2000","journal-title":"BMJ"},{"issue":"23","key":"10.1016\/j.chest.2024.06.3790_bib16","doi-asserted-by":"crossref","first-page":"2222","DOI":"10.1056\/NEJMoa1516385","article-title":"Indacaterol-glycopyrronium versus salmeterol-fluticasone for COPD","volume":"374","author":"Wedzicha","year":"2016","journal-title":"N\u00a0Engl J Med"},{"issue":"9","key":"10.1016\/j.chest.2024.06.3790_bib17","doi-asserted-by":"crossref","first-page":"1189","DOI":"10.1164\/rccm.201701-0193OC","article-title":"Blood eosinophils and response to maintenance chronic obstructive pulmonary disease treatment. Data from the FLAME trial","volume":"195","author":"Roche","year":"2017","journal-title":"Am J Respir Crit Care Med"},{"issue":"1","key":"10.1016\/j.chest.2024.06.3790_bib18","doi-asserted-by":"crossref","first-page":"1800427","DOI":"10.1183\/13993003.00427-2018","article-title":"The reproducibility of COPD blood eosinophil counts","volume":"52","author":"Southworth","year":"2018","journal-title":"Eur Respir J"},{"issue":"6","key":"10.1016\/j.chest.2024.06.3790_bib19","first-page":"670","article-title":"Interlaboratory reproducibility of blood morphology using the digital microscope","volume":"20","author":"Riedl","year":"2015","journal-title":"J\u00a0Lab Autom"},{"issue":"1","key":"10.1016\/j.chest.2024.06.3790_bib20","doi-asserted-by":"crossref","first-page":"4","DOI":"10.1186\/s12931-019-0972-7","article-title":"Treatment response to indacaterol\/glycopyrronium versus salmeterol\/fluticasone in exacerbating COPD patients by gender: a post-hoc analysis in the FLAME study","volume":"20","author":"Wedzicha","year":"2019","journal-title":"Respir Res"},{"issue":"4","key":"10.1016\/j.chest.2024.06.3790_bib21","doi-asserted-by":"crossref","first-page":"382","DOI":"10.1080\/15412555.2017.1313827","article-title":"Stability of blood eosinophil count in patients with COPD in the UK Clinical Practice Research Datalink","volume":"14","author":"Landis","year":"2017","journal-title":"COPD"},{"issue":"6","key":"10.1016\/j.chest.2024.06.3790_bib22","doi-asserted-by":"crossref","first-page":"2000351","DOI":"10.1183\/13993003.00351-2020","article-title":"Withdrawal of inhaled corticosteroids in COPD: a European Respiratory Society guideline","volume":"55","author":"Chalmers","year":"2020","journal-title":"Eur Respir J"},{"issue":"12","key":"10.1016\/j.chest.2024.06.3790_bib23","doi-asserted-by":"crossref","first-page":"1488","DOI":"10.1164\/rccm.202009-3448OC","article-title":"Inflammatory endotype-associated airway microbiome in chronic obstructive pulmonary disease clinical stability and exacerbations: a multicohort longitudinal analysis","volume":"203","author":"Wang","year":"2021","journal-title":"Am J Respir Crit Care Med"},{"issue":"4","key":"10.1016\/j.chest.2024.06.3790_bib24","doi-asserted-by":"crossref","first-page":"2203","DOI":"10.1111\/jcmm.16206","article-title":"The relationship between airway immunoglobulin activity and eosinophils in COPD","volume":"25","author":"Southworth","year":"2021","journal-title":"J\u00a0Cell Mol Med"},{"issue":"1","key":"10.1016\/j.chest.2024.06.3790_bib25","doi-asserted-by":"crossref","first-page":"289","DOI":"10.1186\/s12931-020-01552-4","article-title":"Bacteria and sputum inflammatory cell counts; a COPD cohort analysis","volume":"21","author":"Beech","year":"2020","journal-title":"Respir Res"},{"issue":"3","key":"10.1016\/j.chest.2024.06.3790_bib26","doi-asserted-by":"crossref","first-page":"463","DOI":"10.1016\/j.ccm.2020.05.005","article-title":"Long-acting bronchodilators for chronic obstructive pulmonary disease: Which one(s), how, and when?","volume":"41","author":"Mathioudakis","year":"2020","journal-title":"Clin Chest Med"},{"issue":"8","key":"10.1016\/j.chest.2024.06.3790_bib27","doi-asserted-by":"crossref","first-page":"699","DOI":"10.1016\/S2213-2600(19)30176-6","article-title":"Eosinophil-guided corticosteroid therapy in patients admitted to hospital with COPD exacerbation (CORTICO-COP): a multicentre, randomised, controlled, open-label, non-inferiority trial","volume":"7","author":"Sivapalan","year":"2019","journal-title":"Lancet Respir Med"},{"issue":"12","key":"10.1016\/j.chest.2024.06.3790_bib28","doi-asserted-by":"crossref","first-page":"1578","DOI":"10.1164\/rccm.201807-1289LE","article-title":"Time of day affects eosinophil biomarkers in asthma: implications for diagnosis and treatment","volume":"198","author":"Durrington","year":"2018","journal-title":"Am J Respir Crit Care Med"}],"container-title":["CHEST"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0012369224045951?httpAccept=text\/xml","content-type":"text\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0012369224045951?httpAccept=text\/plain","content-type":"text\/plain","content-version":"vor","intended-application":"text-mining"}],"deposited":{"date-parts":[[2024,12,4]],"date-time":"2024-12-04T18:34:49Z","timestamp":1733337289000},"score":1,"resource":{"primary":{"URL":"https:\/\/linkinghub.elsevier.com\/retrieve\/pii\/S0012369224045951"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2024,11]]},"references-count":28,"journal-issue":{"issue":"5","published-print":{"date-parts":[[2024,11]]}},"alternative-id":["S0012369224045951"],"URL":"https:\/\/doi.org\/10.1016\/j.chest.2024.06.3790","relation":{"has-preprint":[{"id-type":"doi","id":"10.1101\/2023.10.06.23296651","asserted-by":"object"}]},"ISSN":["0012-3692"],"issn-type":[{"value":"0012-3692","type":"print"}],"subject":[],"published":{"date-parts":[[2024,11]]},"assertion":[{"value":"Elsevier","name":"publisher","label":"This article is maintained by"},{"value":"Rethinking Blood Eosinophils for Assessing Inhaled Corticosteroids Response in COPD","name":"articletitle","label":"Article Title"},{"value":"CHEST","name":"journaltitle","label":"Journal Title"},{"value":"https:\/\/doi.org\/10.1016\/j.chest.2024.06.3790","name":"articlelink","label":"CrossRef DOI link to publisher maintained version"},{"value":"article","name":"content_type","label":"Content Type"},{"value":"\u00a9 2024 The Author(s). Published by Elsevier Inc under license from the American College of Chest Physicians.","name":"copyright","label":"Copyright"}]}}